# BALVERSA

NDC: 59676-050
Generic name: Erdafitinib
Labeler / Manufacturer: Janssen Products LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190412

FDA application: NDA212018

## Active ingredients

- ERDAFITINIB: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59676-050"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59676-050
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee